These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12354869)

  • 1. Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp.
    Leverstein-van Hall MA; Fluit AC; Paauw A; Box AT; Brisse S; Verhoef J
    J Clin Microbiol; 2002 Oct; 40(10):3703-11. PubMed ID: 12354869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended-spectrum β-lactamases of Escherichia coli and Klebsiella pneumoniae screened by the VITEK 2 system.
    Espinar MJ; Rocha R; Ribeiro M; Gonçalves Rodrigues A; Pina-Vaz C
    J Med Microbiol; 2011 Jun; 60(Pt 6):756-760. PubMed ID: 21330411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Phoenix and VITEK 2 extended-spectrum-beta-lactamase detection tests for analysis of Escherichia coli and Klebsiella isolates with well-characterized beta-lactamases.
    Thomson KS; Cornish NE; Hong SG; Hemrick K; Herdt C; Moland ES
    J Clin Microbiol; 2007 Aug; 45(8):2380-4. PubMed ID: 17596369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative assessment of the Vitek 2 and Phoenix systems for detection of extended-spectrum beta-lactamases].
    Treviño M; Martínez-Lamas L; Romero-Jung P; Varón C; Moldes L; García-Riestra C; Regueiro BJ
    Enferm Infecc Microbiol Clin; 2009 Dec; 27(10):566-70. PubMed ID: 19473732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures.
    Wiegand I; Geiss HK; Mack D; Stürenburg E; Seifert H
    J Clin Microbiol; 2007 Apr; 45(4):1167-74. PubMed ID: 17287329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of Vitek 2 performance for identifying extended spectrum beta-lactamases in Enterobacteriaceae "other than Escherichia coli, Proteus mirabilis and Klebsiella spp"].
    Diamante P; Camporese A
    Infez Med; 2006 Dec; 14(4):216-26. PubMed ID: 17380089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of detection of extended-spectrum beta-lactamases among Escherichia coli and Klebsiella spp. isolates by VITEK 2 AST-N029 compared to the agar dilution and disk diffusion methods.
    Nyberg SD; Meurman O; Jalava J; Rantakokko-Jalava K
    Scand J Infect Dis; 2008; 40(5):355-62. PubMed ID: 17934979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands.
    Sturm PD; Bochum ET; van Mook-Vermulst SV; Handgraaf C; Klaassen T; Melchers WJ
    Microb Drug Resist; 2010 Mar; 16(1):55-60. PubMed ID: 20001741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the Phoenix automated microbiology system for detecting extended-spectrum beta-lactamase in Escherichia coli, Klebsiella species and Proteus mirabilis].
    Lee KK; Kim ST; Hong KS; Huh HJ; Chae SL
    Korean J Lab Med; 2008 Jun; 28(3):185-90. PubMed ID: 18594169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of extended-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae with Vitek ESBL test.
    Sanders CC; Barry AL; Washington JA; Shubert C; Moland ES; Traczewski MM; Knapp C; Mulder R
    J Clin Microbiol; 1996 Dec; 34(12):2997-3001. PubMed ID: 8940437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital.
    Vercauteren E; Descheemaeker P; Ieven M; Sanders CC; Goossens H
    J Clin Microbiol; 1997 Sep; 35(9):2191-7. PubMed ID: 9276386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of extended-spectrum beta-lactamase (ESBL)-producing Kuwait and UK strains identified by the Vitek system, and subsequent comparison of the Vitek system with other commercial ESBL-testing systems using these strains.
    Dashti AA; West P; Paton R; Amyes SGB
    J Med Microbiol; 2006 Apr; 55(Pt 4):417-421. PubMed ID: 16533989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of a novel, inhibitor-potentiated disc-diffusion test with other methods for the detection of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae.
    Ho PL; Chow KH; Yuen KY; Ng WS; Chau PY
    J Antimicrob Chemother; 1998 Jul; 42(1):49-54. PubMed ID: 9700527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended-spectrum beta-lactamase-producing Klebsiella spp.
    West PW
    Br J Biomed Sci; 2000; 57(3):226-33. PubMed ID: 11050776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
    Mohanty S; Gaind R; Ranjan R; Deb M
    J Infect Dev Ctries; 2009 Nov; 4(1):24-9. PubMed ID: 20130375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-centre evaluation of a phenotypic extended spectrum β-lactamase detection guideline in the routine setting.
    Platteel TN; Cohen Stuart JW; de Neeling AJ; Voets GM; Scharringa J; van de Sande N; Fluit AC; Bonten MJM; Leverstein-van Hall MA;
    Clin Microbiol Infect; 2013 Jan; 19(1):70-76. PubMed ID: 22268620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P; Metan G; Hasçelik G; Akova M
    Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
    Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
    P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
    Moland ES; Sanders CC; Thomson KS
    J Clin Microbiol; 1998 Sep; 36(9):2575-9. PubMed ID: 9705395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory diagnosis of bloodstream infections caused by extended-spectrum beta-lactamase-producing E. coli and Klebsiella species.
    Skippen I; Shemko M; Palmer C; Shetty N
    Br J Biomed Sci; 2006; 63(1):1-4. PubMed ID: 16613133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.